RT @radcliffeCARDIO: Bryan Zweig, MD discusses how data from the CLASP IID and TRISCEND II trials have influenced his referral management f….

Left atrial appendage exclusion has been shown to reduce ischemic stroke risk for AF patients undergoing concomitant surgery. Refer your patients to surgical LAAE for effective stroke* risk reduction. *Originating from the LAA. Learn more about LAA Exclusion

Is your knowledge up to date on LBBAP and how it compares with conventional pacing?. The advantages?. The patient selection criteria?. Prof Jan De Pooter, Dr Kartikeya Bhargava and Prof Chi-Keong Ching share how you can streamline your LBBAP procedures, with essential tools,

RT @RadcliffeCVRM: 🚨 Live in one hour – Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy. Register here 👉 .

RT @Transcatheter: 🎙️NEW #NYValves2025 #LBCT Interview 💫Dr @p_grayburn discusses echocardiographic outcomes from the TRISCEND II substudy.….

Prof @CuissetDr outlines how to structure an effective pulmonary embolism (PE) response network with coordinated teams and clear referral pathways. Got a spare 12 minutes? Stream the full session 'Informed Decisions: Expanding Options for PE Patients' for practical strategies in

📚New #JAPSCJournal Article: "Hyperkalaemia in Acute Heart Failure: An Asian Population Study". 📚 Just Published!. 🔓Access it here 👉 @apsc_office #HeartFailure #CardioTwitter #MedEd

RT @Transcatheter: 🎙️ NEW #NYValves2025 Interview 💫 Dr Santiago Garcia discusses outcomes from on the #PASCAL system. 📽️ Watch in full her….

Prof Roland Tilz showcases efficient workflows using the Volt™ balloon – mapping and isolating with precision, even in patients with pacemakers or ICDs. Watch the full recorded case now: #EPeeps #PFA #AFib @RolandTilz

RT @Transcatheter: 🎙️NEW #NYValves2025 #LBCT Interview 💫Dr Santiago Garcia discusses outcomes from a study investigating early outcomes of….

📚New #ECRJournal Article: "Development of Small-molecule SERCA Stimulators". 📚 Just Published!. 🔓Access it here 👉 #HeartFailure #CardioTwitter #MedEd

📚Discover these recently published articles in #ECRJournal (#ImpactFactor: 3.6)✨. 📄New Insights into Uric Acid Metabolism in the Pathophysiology of Ischaemic Heart Disease 👉 📄Oral #P2Y12 Inhibitors: Victims or Perpetrators? A Focused Review on

📢 We’ve just launched Transcatheter Academy – Radcliffe Cardiology’s home for interventional education. Follow for focused insights, practical takeaways, and expert-led content – all in one place!.

When should you refer a patient with tricuspid regurgitation? In this session, Brian O’Neill, MD discusses why early referral is key for patients with severe TR on diuretics. He highlights that patients who experience fatigue and low cardiac output may still benefit from therapy.

💫 Join Prof James Burton, Dr @BonanadClara, Dr Aaron Wong and Dr Csaba Kovesdy for live webinar designed to help you feel more confident managing hyperkalaemia 👉 . 📚 They will cover: .• How to keep RAASi therapy on track .• The impact of

📢 We’ve just launched Transcatheter Academy – Radcliffe Cardiology’s home for interventional education. Follow for focused insights, practical takeaways, and expert-led content – all in one place!.

RT @ISCPcardio: Going live very shortly!! #ISCPendorsed webinar produced by @radcliffeCARDIO - Managjng #hypertension in CVD: How Low Can W….

Are you recommending LAA Exclusion to reducestroke* risk?.LAA Exclusion reduces the risk of LAA-relatedstroke by over 40%. Endorsed by top medicalbodies, it's recommended that you recommend it. - ESC supported by EACTS (Class I Recommendation).- American College of

🎙️NEW #NYValves2025 #LBCT Interview 💫Prof Ole De Backer discusses the current landscape of #TAVR in 2025. 📽️Watch here👉 #CardioX #CardioTwitter #CardioEd